Sarepta治疗 SRPT 深 沪
等待开盘 08-13 09:30:00 美东时间
18.60
+0.660
+3.68%
华盛通- 最 高18.605
- 今 开17.95
- 成交量 455.15万股
- 最 低 17.68
- 昨 收 17.94
- 总市值 18.28亿
- 52周最高 141.72
- 市盈率 静 7.95
- 换手率 4.63%
- 52周最低 10.415
- 委 比 54.46%
- 总股本 9827.70万
- 历史最高 181.83
- 量 比 0.41
- 振 幅 5.16%
- 历史最低 0.433
- 每 手 1
- 风险率 19.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction
Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA vaccine oversight.
08-11 20:45
C3.ai, Destiny Tech100 And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around...
08-11 20:45
FDA争议官员回归引爆抛售潮！美股生物科技板块盘前下挫
周一美股盘前，多家生物科技公司股价出现下跌。此前有报道称，曾被解职的美国食品药品监督管理局(FDA)疫苗监管官员Vinay Prasad将重返该机构。
08-11 19:42
Biotech sector slips amid reported return of ousted FDA official
Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration vaccine regulator Vinay Prasad will return to the agency. Prasad, who had o...
08-11 18:25
FDA reinstates top vaccines regulator just days after his abrupt departure
At the U.S. Food and Drug Administration's (FDA) request, Vinay Prasad is returning to the role of director of the Center for Biologics Evaluation and Research, just ten days after departing the agenc...
08-10 04:46
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
What 43 Analyst Ratings Have To Say About Sarepta Therapeutics
In the preceding three months, 43 analysts have released ratings for Sarepta Th...
08-08 03:01
'Sarepta hired a Trump-connected firm to lobby on Duchenne treatment'- STAT News
https://www.statnews.com/2025/08/06/sarepta-lobbying-firm-duchenne-michael-best-strategies-connected-to-trump/
08-07 01:12
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
